Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells
NCT00020072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2015-04-29
Summary
RATIONALE: Analyzing genes that are present in cancer cells may be useful in developing better methods to detect, predict, and treat cutaneous T-cell lymphoma.
PURPOSE: Clinical trial to study genes that are present in cutaneous T-cell lymphoma cells.
Conditions
Interventions
- OTHER
-
laboratory biomarker analysis
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Sam T. Hwang, MD, PhD · NCI - Dermatology Branch
Study Design
- Purpose
- DIAGNOSTIC
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-03-31
Countries
- United States
Study Locations
More Related Trials
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
NCT00066664 ·Status: COMPLETED ·Phase: NA
-
DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402
NCT01406782 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
NCT01505712 ·Status: COMPLETED
-
Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes
NCT02355587 ·Status: TERMINATED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
NCT00981097 ·Status: COMPLETED
-
Genetic Analysis of Brain Tumors
NCT00031538 ·Status: TERMINATED
-
Clinical Genetics Branch Eligibility Screening Survey
NCT07005297 ·Status: NOT_YET_RECRUITING
-
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
NCT01366170 ·Status: COMPLETED
-
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
NCT00131014 ·Status: RECRUITING
-
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
NCT00899132 ·Status: TERMINATED
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
NCT01528956 ·Status: COMPLETED
-
Sample Collection and Tracking for the Developmental Therapeutics Clinic
NCT03269578 ·Status: RECRUITING